Scientific Program

SESSION 1:	Technical Advances in Functional Lung Imaging

Chair: Yoshi Ohno	Past, Present and Future of Functional Lung Imaging Edwin van Beek Functional Lung Imaging with Proton MRI - state of the art Andreas Voskrebenzev 19F and 129 Xe Lung MRI – ready for clinical translation Jim Wild The emerging role for PET imaging in Lung disease Delphine Chen Deep learning: a quantum leap for Lung Imaging Joon Beom Seo

Industry Exhibition Break

SESSION 2:	Lung Cancer

Chair: Hans Ulrich Kauczor Jin Mo Goo	LC screening: scientific evidence and epidemiological considerations Rudolf Kaaks LC screening: Nodule management – Present and Future Matthijs Oudkerk LC Screening: What about the heart and other lung disease? Jens Vogel-Claussen How to build an effective screening program David Baldwin Therapy response Imaging – Current Status and novel developments Mizuki Nishino Hatabu

Industry Symposium I

SESSION 3:	YIA (Young Investigator Award) Session

Chair: Edwin J.R. van Beek

Industry Exhibition Break

SESSION 4:	Chronic Obstructive Pulmonary Disease (COPD)

Chair: David Lynch	Critical Clinical Issues in COPD tba The value of cardiopulmonary imaging in COPD cohort studies Graham Barr Novel Structure-Function CT markers in COPD Eric Hoffman Functional Lung MRI - emerging role in COPD Hiroto Hatabu

Industry Symposium II

POSTER SESSION

SESSION 5:	Asthma

Chair: Grace Parraga	Critical Clinical Issues in Asthma Erika von Mutius Role of MR Functional Imaging Grace Parraga Role of CT Functional Imaging Yoshi Ohno

Industry Exhibition Break

SESSION 6:	Pulmonary Vascular Disease

Chair: Marius Hoeper	Pulmonary Hypertension - the clinical perspective Marius Hoeper The role of imaging in pulmonary hypertension Andy Swift Pulmonary embolism: Acute, Chronic and AI Mark Schiebler Hyperpolarized 129Xe MRI for novel insights into Pulmonary Vascular Disease Bastiaan Driehuys

Industry Symposium III

SESSION 7:	Infection and Inflammation

Chair: Tobias Welte Mark Schiebler	Lessons learned from the COVID-19 pandemic Tobias Welte COVID-19 - the role of imaging and future perspectives Hans Ulrich Kauczor COVID-19 – Novel insights from Microstructure Imaging Danny Jonigk

Industry Exhibition Break

SESSION 8:	Interstitial Lung Disease (ILD)

Chair: Juergen Biederer Hiroto Hatabu	ILDs - What the radiologist needs to know David Lynch Critical Clinical Issues in IPF Antje Prasse Novel CT biomarker for monitoring ILD Jin Mo Goo The emerging role of functional lung MRI in ILD Christopher Johns

Industry Symposium IV

EVENING EVENT	Dinner at Hannover New Town Hall

SESSION 9:	Lung Microstructure

Chair: Eric Hoffman Jens Vogel-Claussen	Multiscale imaging of the human lung Willi Wagner Microstructure Imaging of the lung with hyperpolarized Gas MRI Agilo Kern New Horizons: Dark field imaging of the lungs Franz Pfeiffer Photon Counting CT: The new clinical standard for lung imaging? tba

SESSION 10:	Pediatric Lung Disease

Chair: Giles Santyr Jason Woods	The emerging clinical role of functional lung MRI in newborns and infants Jason Woods The growing clinical role of functional lung MRI in CF Mark Wielpütz Opportunities of hyperpolarized 129Xe gas MRI in children with lung disease Giles Santyr